Company GW Pharmaceuticals plc London S.E.
Equities
GB0030544687
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- GBX | 0.00% |
Aug. 12 | Jazz Pharmaceuticals : U.S. FDA approves expanded use of Jazz Pharma's sleep disorder drug Xywav | RE |
Aug. 10 | Sector Update: Health Care Stocks Steady Premarket Tuesday | MT |
Business Summary
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 378,505,496 | 370,720,441 ( 97.94 %) | 0 | 97.94 % |
Company contact information
GW Pharmaceuticals Ltd.
Sovereign House Vision Park, Chivers Way
CB24 9BZ, Cambridge
+44 1223 266 800
http://gwpharm.comGroup companies
Name | Category and Sector |
---|---|
GW Research Ltd.
GW Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Jazz Pharmaceuticals Plc, GW Research Ltd. is a British company founded in 1995. The private company is based in Cambridge, UK. GW Research is focused on improving patients’ lives by identifying, developing, and commercializing products that address unmet medical needs. |
Miscellaneous Commercial Services
|
GWP Trustee Co. Ltd.
GWP Trustee Co. Ltd. Financial ConglomeratesFinance Part of Jazz Pharmaceuticals Plc, GWP Trustee Co. Ltd. engages in activities of other holding companies. The private company is located in UK. |
Financial Conglomerates
|
GW Pharma Ltd.
GW Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, GW Pharma Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in Histon, UK. GW Pharma was founded in 1999. |
Pharmaceuticals: Major
|
Sector
1st Jan change | Capi. | |
---|---|---|
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |
- Stock
- Equities
- Stock GW Pharmaceuticals plc
- Stock GW Pharmaceuticals plc - London S.E.
- Company GW Pharmaceuticals plc